,101 Experimental studies have also indicated that SPP1 is essential in vascular remodelling, and restenosis.100, 101, 102 Atherosclerosis-modifying therapies with statins or angiotensin II receptor antagonists (ARBs) simultaneously reduce cardiovascular disease risk and circulating SPP1 levels.103. Here, SPP1 is linked to atherosclerosis.